Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action
10.1016/j.phrs.2021.105647 · doi-reference
Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics
10.1016/j.biopha.2019.109362 · doi-reference
Mechanism study of the protective effects of sodium tanshinone IIA sulfonate against atorvastatin-induced cerebral hemorrhage in zebrafish: Transcriptome analysis
10.3389/fphar.2020.551745 · doi-reference
Gambogic acid improves non-small cell lung cancer progression by inhibition of the mTOR signaling pathway
10.1016/j.kjms.2017.06.013 · doi-reference
Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia
10.1016/j.cbi.2008.04.049 · doi-reference
TRIM46 contributes to high glucose-induced ferroptosis and cell growth inhibition in human retinal capillary endothelial cells by facilitating GPX4 ubiquitination
10.1016/j.yexcr.2021.112800 · doi-reference
Naringenin attenuates inflammation, apoptosis, and ferroptosis in silver nanoparticle-induced lung injury through a mechanism associated with the Nrf2/HO-1 axis: In vitro and in vivo studies
10.1016/j.lfs.2022.121127 · doi-reference
Identification and experimental validation of ferroptosis-related gene lactotransferrin in age-related hearing loss
10.3389/fnagi.2024.1309115 · doi-reference
Kaempferol ameliorates oxygen-glucose deprivation/reoxygenation-induced neuronal ferroptosis by activating the Nrf2/SLC7A11/GPX4 axis
10.3390/biom11070923 · doi-reference
Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases
10.1038/s41420-021-00579-w · doi-reference
Leonurine ameliorates diabetic nephropathy through GPX4-mediated ferroptosis of endothelial cells
10.31083/j.fbl2907270 · doi-reference
Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis
10.1038/s41467-019-10991-7 · doi-reference
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
10.1042/bsr20193314 · doi-reference
Ginsenoside Re attenuates myocardial ischemia/reperfusion-induced ferroptosis via miR-144-3p/SLC7A11
10.1016/j.phymed.2023.154681 · doi-reference
Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin
10.1074/jbc.m114.564567 · doi-reference
Ferroptosis-inhibitory difference between chebulagic acid and chebulinic acid indicates the beneficial role of HHDP
10.3390/molecules26144300 · doi-reference
Prevention and treatment of osteoporosis with natural products: Regulatory mechanism based on cell ferroptosis
10.1186/s13018-023-04448-3 · doi-reference
Ferroptosis-mediated osteoclast-osteoblast crosstalk: signaling pathways governing bone remodeling in osteoporosis
10.1186/s13018-025-06315-9 · doi-reference
The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma
10.1016/j.celrep.2019.07.107 · doi-reference
Living cell-target responsive accessibility profiling reveals silibinin targeting ACSL4 for combating ferroptosis
10.1021/acs.analchem.2c03515 · doi-reference
Ferroptosis: mechanisms and links with diseases
10.1038/s41392-020-00428-9 · doi-reference
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105
10.1200/jco.2009.24.5050 · doi-reference
Ferroptosis and the bidirectional regulatory factor p53
10.1038/s41420-023-01517-8 · doi-reference
The interplay between ferroptosis and neuroinflammation in central neurological disorders
10.3390/antiox13040395 · doi-reference
The emerging role of ferroptosis in intestinal disease
10.1038/s41419-021-03559-1 · doi-reference
Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway
10.1016/j.freeradbiomed.2022.09.001 · doi-reference
Inhibition of ferroptosis attenuates tissue damage and improves long-term outcomes after traumatic brain injury in mice
10.1111/cns.13069 · doi-reference
Biological drug and drug delivery-mediated immunotherapy
10.1016/j.apsb.2020.12.018 · doi-reference
Honokiol targeting SIRT3: From molecular mechanisms to therapeutic opportunities
10.1096/fj.202501428r · doi-reference
Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease
10.7554/elife.40048 · doi-reference
Ginsenoside Rh3 induces pyroptosis and ferroptosis through the STAT3/p53/NRF2 axis in colorectal cancer cells
10.3724/abbs.2023068 · doi-reference
Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling
10.1038/s41586-019-1426-6 · doi-reference
Inhibition of Akt/mTOR/p70S6K signaling activity with Huangkui capsule alleviates the early glomerular pathological changes in diabetic nephropathy
10.3389/fphar.2018.00443 · doi-reference
An update on the role of ferroptosis in the pathogenesis of osteoporosis
10.1530/eor-23-0148 · doi-reference
Inflammation in a ferroptotic environment
10.3389/fphar.2024.1474285 · doi-reference
Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway
10.1016/j.jhazmat.2019.121390 · doi-reference
Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
10.1021/ja00738a045 · doi-reference
P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation
10.1002/iub.1895 · doi-reference
Berberine inhibits ferroptosis and stabilizes atherosclerotic plaque through the NRF2/SLC7A11/GPX4 pathway
10.1007/s11655-024-3666-z · doi-reference
Artemisinin, the magic drug discovered from traditional Chinese medicine
10.1016/j.eng.2018.11.011 · doi-reference
